TYCC
GILD icon

Texas Yale Capital Corp’s Gilead Sciences GILD Stock Holding History

Texas Yale Capital Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Hold
2,135
– – 0.01% 462
2026
Q1 		$298K Hold
2,135
– – 0.01% 432
2025
Q4 		$262K Buy
2,135
+200
+10% +$24.3K 0.01% 437
2025
Q3 		$215K Hold
1,935
– – 0.01% 464
2025
Q2 		$215K Hold
1,935
– – 0.01% 442
2025
Q1 		$217K Buy
+1,935
New +$200K 0.01% 426
2015
Q1 		– Sell
-2,574
Closed -$243K – 474
2014
Q4 		$243K Hold
2,574
– – 0.02% 422
2014
Q3 		$274K Buy
+2,574
New +$252K 0.03% 379

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Texas Yale Capital Corp's GILD Position: Q2 2026 in Review

Texas Yale Capital Corp held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,135 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #462.

Texas Yale Capital Corp first reported a position in GILD in Q3 2014 and has held it in 8 quarters since. The position peaked at $298K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Texas Yale Capital Corp held 2,135 shares of Gilead Sciences worth $270K as of Q2 2026.
  • Texas Yale Capital Corp left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Texas Yale Capital Corp's portfolio in Q2 2026, its #462 holding.
  • Texas Yale Capital Corp first reported a position in Gilead Sciences in Q3 2014 and has held it in 8 quarters since.
  • Texas Yale Capital Corp's Gilead Sciences position peaked at $298K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.